Tyrosine Phosphorylation Sites

Abstract

The invention discloses 482 novel phosphorylation sites identified in carcinoma and/or leukemia, peptides (including AQUA peptides) comprising a phosphorylation site of the invention, antibodies specifically bind to a novel phosphorylation site of the invention, and diagnostic and therapeutic uses of the above.


Claims
Owners (US)

Information currently unavailable.

Download Citation


Sign in to the Lens

Feedback